TABLE 3.
Echocardiographic parameters for groups aPH and non‐aPH
Variable | Non‐aPH (n = 41) | aPH (n = 26) |
---|---|---|
Tricuspid valve insufficiency (yes/no) | 8/33 [n = 41] | 26/0 [n = 26] |
TR velocity (m/s) | 2.5 (2.2‐2.6) [n = 8] | 3.2 (2.6‐3.9) [n = 26] |
Estimated sPAP (mmHg) | 32 (22‐35) [n = 8] | 50 (37‐76) [n = 26] |
PAAT (ms) | 100 (65‐146) [n = 36] | 84 (50‐130) [n = 21] |
≤90 ms (n) | 9 | 13 |
IVC diameter (mm) | 19 (9‐37) [n = 40] | 23 (14‐29) [n = 26] |
Estimated RAP (mmHg) | 8 (0‐15) [n = 40] | 11.5 (3‐15) [n = 26] |
RV size and function | ||
RV dilatation (yes/no) | 13/25 [n = 38] | 14/12 [n = 26] |
RV basal diameter in 4‐chamber view (mm) |
38 (29‐51) [n = 37] | 42.5 (30‐53) [n = 26] |
TAPSE (mm) | 21 (14‐30) [n = 38] | 23.5 (15‐31) [n = 26] |
RV s´ (m/s) | 0.15 (0.08‐0.22) [n = 29] | 0.17 (0.13‐0.22) [n = 22] |
RV global systolic function (normal/impaired) | 27/13 [n = 40] | 17/9 [n = 26] |
RV radial function (normal/impaired) | 26/14 [n = 40] | 14/12 [n = 26] |
LV size and function | ||
LVEDD (mm) | 50 (34‐60) [n = 38] | 49 (4052) [n = 26] |
LVEF (%) | 55 (40‐80) [n = 41] | 58 (50‐75) [n = 26] |
LVEF (normal/impaired) | 31/10 [n = 41] | 22/4 [n = 26] |
Data presented as median (range) or n, as appropriate.
Abbreviations: IVC, inferior vena cava; LVEDD, left ventricular end‐diastolic diameter; LVEF, left ventricular ejection fraction; PAAT, pulmonary artery acceleration time; RAP, right atrial pressure; RV, right ventricle; s´, peak systolic Doppler tissue velocity recorded in RV close to tricuspid annulus; sPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.